Form 4 for LGND LIGAND PHARMACEUTICALS INC
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0002001011-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-19 | 2025-02-14+ | LGND | Espinoza Octavio | CFO | F - Tax | $120.00 | -9,587 | 23.3K | -29% | -$1.15M |
| M | 2025-02-19 | 2025-02-14 | LGND | Espinoza Octavio | CFO | A - Grant | $0.00 | +12.8K | 30.7K | +72% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | F | D | 3,803 | $120.00 | 26,906 | D | — | — | (F2) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units. |
| 2 | Common | Common Stock | 2025-02-15 | F | D | 1,024 | $120.00 | 25,882 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |
| 3 | Common | Common Stock | 2025-02-15 | F | D | 782 | $120.00 | 25,100 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |
| 4 | Common | Common Stock | 2025-02-15 | F | D | 1,221 | $120.00 | 23,879 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |
| 5 | Common | Common Stock | 2025-02-14 | A | A | 5,429 | $0.00 | 26,076 | D | — | — | (F1) Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs). |
| 6 | Common | Common Stock | 2025-02-14 | F | D | 2,757 | $120.00 | 23,319 | D | — | — | (F2) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units. |
| 7 | Common | Common Stock | 2025-02-14 | A | A | 7,390 | $0.00 | 30,709 | D | — | — | (F1) Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs). |